PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan
ARKG vs. CNCR
Performance
Return for Risk
Drawdowns
Volatility
Dividends

ARKG vs. CNCR

Last updated Jun 24, 2026

ARKG (ARK Genomic Revolution Multi-Sector ETF) and CNCR (Loncar Cancer Immunotherapy ETF) are both Health & Biotech Equities funds. ARKG is actively managed, while CNCR is passively managed. ARKG charges 0.75%/yr vs 0.79%/yr for CNCR.

Performance

ARKG vs. CNCR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ARK Genomic Revolution Multi-Sector ETF (ARKG) and Loncar Cancer Immunotherapy ETF (CNCR). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

ARKG

1D
-1.07%
1M
17.41%
YTD
24.30%
6M
19.48%
1Y
52.71%
3Y*
3.17%
5Y*
-16.56%
10Y*
8.67%

CNCR

1D
0.00%
1M
0.00%
YTD
—
6M
—
1Y
—
3Y*
—
5Y*
—
10Y*
—
*Multi-year figures are annualized to reflect compound growth (CAGR)

ARKG vs. CNCR - Yearly Performance Comparison

2026 (YTD)
ARKG
ARK Genomic Revolution Multi-Sector ETF		30.99%
CNCR
Loncar Cancer Immunotherapy ETF		0.00%

ARKG vs. CNCR - Sectors Allocation Comparison

Sectors
ARKG
CNCR

Healthcare

99.3%
96.6%

Financial Services

0.5%
3.3%

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

ARKG
99.3%
CNCR
96.6%

Financial Services

ARKG
0.5%
CNCR
3.3%

Basic Materials

ARKG

-

CNCR

-

Communication Services

ARKG

-

CNCR

-

Consumer Cyclical

ARKG

-

CNCR

-

Consumer Defensive

ARKG

-

CNCR

-

Energy

ARKG

-

CNCR

-

Industrials

ARKG

-

CNCR

-

Real Estate

ARKG

-

CNCR

-

Technology

ARKG

-

CNCR

-

Utilities

ARKG

-

CNCR

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

ARK Genomic Revolution Multi-Sector ETF

Loncar Cancer Immunotherapy ETF

Often compared with ARKG:
ARKG vs. ARKKARKG vs. XBIARKG vs. IBBARKG vs. GNOMARKG vs. IDNAARKG vs. ARKQARKG vs. ARKW
Often compared with CNCR:
CNCR vs. SCHDCNCR vs. XBICNCR vs. IYHCNCR vs. IBBQCNCR vs. SMHCNCR vs. SPMOCNCR vs. VB

Return for Risk

ARKG vs. CNCR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
ARKG
ARKG Risk / Return Rank: 3636
Overall Rank
ARKG Sharpe Ratio Rank: 3636
Sharpe Ratio Rank
ARKG Sortino Ratio Rank: 3838
Sortino Ratio Rank
ARKG Omega Ratio Rank: 3434
Omega Ratio Rank
ARKG Calmar Ratio Rank: 4040
Calmar Ratio Rank
ARKG Martin Ratio Rank: 3232
Martin Ratio Rank
CNCR

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ARKG vs. CNCR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ARK Genomic Revolution Multi-Sector ETF (ARKG) and Loncar Cancer Immunotherapy ETF (CNCR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

ARKGCNCRDifference
Sharpe ratioReturn per unit of total volatility
1.25

—

—

Sortino ratioReturn per unit of downside risk
1.91

—

—

Omega ratioGain probability vs. loss probability

1.22

—

—

Calmar ratioReturn relative to maximum drawdown

1.93

—

—

Martin ratioReturn relative to average drawdown

4.58

—

—

ARKG vs. CNCR - Sharpe Ratio Comparison

Loading charts...

Drawdowns

ARKG vs. CNCR - Drawdown Comparison

The maximum ARKG drawdown since its inception was -83.59%, which is greater than CNCR's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for ARKG and CNCR.

Loading charts...

Drawdown Indicators

ARKGCNCRDifference

Max Drawdown

Largest peak-to-trough decline

-83.59%

0.00%

-83.59%

Max Drawdown (1Y)

Largest decline over 1 year

-27.51%

—

—

Max Drawdown (3Y)

Largest decline over 3 years

-51.96%

—

—

Max Drawdown (5Y)

Largest decline over 5 years

-80.18%

—

—

Max Drawdown (10Y)

Largest decline over 10 years

-83.59%

—

—

Current Drawdown

Current decline from peak

-67.78%

0.00%

-67.78%

Average Drawdown

Average peak-to-trough decline

-36.02%

0.00%

-36.02%

Ulcer Index

Depth and duration of drawdowns from previous peaks

11.53%

—

—

Volatility

ARKG vs. CNCR - Volatility Comparison

Loading charts...

Volatility by Period

ARKGCNCRDifference

Volatility (1M)

Calculated over the trailing 1-month period

15.19%

—

—

Volatility (6M)

Calculated over the trailing 6-month period

30.91%

—

—

Volatility (1Y)

Calculated over the trailing 1-year period

42.54%

0.00%

+42.54%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

45.93%

0.00%

+45.93%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

41.29%

0.00%

+41.29%

ARKG vs. CNCR - Expense Ratio Comparison

ARKG has a 0.75% expense ratio, which is lower than CNCR's 0.79% expense ratio.

Dividends

ARKG vs. CNCR - Dividend Comparison

Neither ARKG nor CNCR has paid dividends to shareholders.

PositionTTM202520242023202220212020201920182017
ARKG
ARK Genomic Revolution Multi-Sector ETF		0.00%0.00%0.00%0.00%0.00%0.62%0.85%3.14%0.82%1.34%
CNCR
Loncar Cancer Immunotherapy ETF		0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions

On fees, ARKG is cheaper at 0.75% per year. The better choice depends on whether you care most about return, fees, risk, or income.

ARKG is cheaper with a 0.75% expense ratio, compared with 0.79% for CNCR.

ARKG and CNCR have nearly identical dividend yields, around 0.00%.

They also come from different issuers: ARK and Exchange Traded Concepts. Their fees differ too: 0.75% for ARKG and 0.79% for CNCR.

Portfolio Optimizer

Find the right allocation for ARKG and CNCR

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer